Stellar-NP Safety Profile

2022 Jul, SatPublications

New publication has been released to demonstrate Stellar-NP safety and efficacy

Title : Starch-based NP act as antigen delivery systems without immunomodulating effect.

Fasquelle et al. 2022 Plos one

Abstract: The nasal route of immunization has become a real alternative to injections. It is indeed described as more efficient at inducing immune protection, since it initiates both mucosal and systemic immunity, thus protecting against both the infection itself and the transmission of pathogens by the host. However, the use of immunomodulators should be limited since they induce inflammation. Here we investigated in vitro the mechanisms underlying the enhancement of antigen immunogenicity by starch nanoparticles (NPL) delivery systems in H292 epithelial cells, as well as the NPL’s immunomodulatory effect. We observed that NPL had no intrinsic immunomodulatory effect but enhanced the immunogenicity of an E. coli lysate (Ag) merely by increasing its intracellular delivery. Moreover, we demonstrated the importance of the NPL density on their efficiency by comparing reticulated (NPL) and non-reticulated particles (NPL·NR). These results show that an efficient delivery system is sufficient to induce a mucosal immune response without the use of immunomodulators.

Keywords: antibacterial vaccines; antiparasitic vaccines; antiviral vaccines; nanoparticles; nasal vaccine.

Access the publication : Here

Stay tuned for more updates as we continue our mission to protect animal and human worldwide! 🐒 🌿